RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $700M
1-Year Est. Return 67.16%
This Quarter Est. Return
1 Year Est. Return
+67.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$700M
AUM Growth
-$785M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1 +$1.39B

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$54.5B
$635M 90.64%
1,392,303
-3,052,142
NTLA icon
2
Intellia Therapeutics
NTLA
$1.11B
$64M 9.13%
3,702,995
ADVM
3
DELISTED
Adverum Biotechnologies
ADVM
$820K 0.12%
180,909
ACET icon
4
Adicet Bio
ACET
$79.2M
$784K 0.11%
968,183